Assessing the Efficacy of Nano- and Micro-Sized Magnetic Particles as Contrast Agents for MRI Cell Tracking

Iron-oxide based contrast agents play an important role in magnetic resonance imaging (MRI) of labelled cells in vivo. Currently, a wide range of such contrast agents is available with sizes varying from several nanometers up to a few micrometers and consisting of single or multiple magnetic cores. Here, we evaluate the effectiveness of these different particles for labelling and imaging stem cells, using a mouse mesenchymal stem cell line to investigate intracellular uptake, retention and processing of nano- and microsized contrast agents. The effect of intracellular confinement on transverse relaxivity was measured by MRI at 7 T and in compliance with the principles of the ‘3Rs’, the suitability of the contrast agents for MR-based cell tracking in vivo was tested using a chick embryo model. We show that for all particles tested, relaxivity was markedly reduced following cellular internalisation, indicating that contrast agent relaxivity in colloidal suspension does not accurately predict performance in MR-based cell tracking studies. Using a bimodal imaging approach comprising fluorescence and MRI, we demonstrate that labelled MSC remain viable following in vivo transplantation and can be tracked effectively using MRI. Importantly, our data suggest that larger particles might confer advantages for longer-term imaging.

[1]  Alan P Koretsky,et al.  Sizing it up: Cellular MRI using micron‐sized iron oxide particles , 2005, Magnetic resonance in medicine.

[2]  R. Blasberg,et al.  Noninvasive Molecular Imaging Using Reporter Genes , 2013, The Journal of Nuclear Medicine.

[3]  Urs O. Häfeli,et al.  Crucial Ignored Parameters on Nanotoxicology: The Importance of Toxicity Assay Modifications and “Cell Vision” , 2012, PloS one.

[4]  W. Fish,et al.  Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples. , 1988, Methods in enzymology.

[5]  A. Koretsky,et al.  Micron-Sized Iron Oxide Particles (MPIOs) for Cellular Imaging: More Bang for the Buck , 2008 .

[6]  C. A. Shaw,et al.  In Vivo Mononuclear Cell Tracking Using Superparamagnetic Particles of Iron Oxide: Feasibility and Safety in Humans , 2012, Circulation Cardiovascular Imaging.

[7]  Luís Curvo-Semedo,et al.  MR Contrast Agents , 2009 .

[8]  M. Wendland,et al.  T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning , 2006, European Radiology.

[9]  Florence Gazeau,et al.  Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties , 2010, Nanotechnology.

[10]  F. Ris,et al.  Clinical Magnetic Resonance Imaging of Pancreatic Islet Grafts After Iron Nanoparticle Labeling , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  W. Heindel,et al.  Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. , 2005, Radiology.

[12]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[13]  M. Devaud,et al.  How cellular processing of superparamagnetic nanoparticles affects their magnetic behavior and NMR relaxivity. , 2012, Contrast media & molecular imaging.

[14]  Alan P Koretsky,et al.  MRI detection of single particles for cellular imaging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Arend Heerschap,et al.  Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.

[16]  D. Fernig,et al.  Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet? , 2012, Chemical Society reviews.

[17]  Sophie Laurent,et al.  Classification and basic properties of contrast agents for magnetic resonance imaging. , 2009, Contrast media & molecular imaging.

[18]  S. Gambhir,et al.  Noninvasive cell-tracking methods , 2011, Nature Reviews Clinical Oncology.

[19]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[20]  Jeff W M Bulte,et al.  In vivo MRI cell tracking: clinical studies. , 2009, AJR. American journal of roentgenology.

[21]  F. Schick,et al.  Measurement of T1, T2, and magnetization transfer properties during embryonic development at 7 Tesla using the chicken model , 2008, Journal of magnetic resonance imaging : JMRI.

[22]  P. Jakob,et al.  Intracellular and extracellular T1 and T2 relaxivities of magneto‐optical nanoparticles at experimental high fields , 2010, Magnetic resonance in medicine.

[23]  P. Jacobs,et al.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[24]  H. Rashidi,et al.  The chick embryo: hatching a model for contemporary biomedical research , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  D. Grainger.  Nanotoxicity assessment: all small talk? , 2009, Advanced drug delivery reviews.

[26]  Jerry S. H. Lee,et al.  Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.

[27]  Liangfu Zhou,et al.  Tracking neural stem cells in patients with brain trauma. , 2006, The New England journal of medicine.

[28]  Jeff W M Bulte,et al.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. , 2003, Radiology.

[29]  Xiaodong Chen,et al.  Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues , 2012, Stem cells translational medicine.

[30]  L. Gauckler,et al.  Change of zeta potential of biocompatible colloidal oxide particles upon adsorption of bovine serum albumin and lysozyme. , 2005, The journal of physical chemistry. B.

[31]  J Bittoun,et al.  Cell internalization of anionic maghemite nanoparticles: Quantitative effect on magnetic resonance imaging , 2003, Magnetic resonance in medicine.

[32]  T. R. Pisanic,et al.  Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. , 2010, Small.

[33]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[34]  T. Skotland,et al.  In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging. , 2002, Journal of pharmaceutical and biomedical analysis.

[35]  Matthew R J Carroll,et al.  Experimental validation of proton transverse relaxivity models for superparamagnetic nanoparticle MRI contrast agents , 2010, Nanotechnology.

[36]  Xavier Montet,et al.  Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures , 2006, Journal of Pharmacology and Experimental Therapeutics.